Brisbane founders can combine Queensland venture teams, angel investors, research-commercialisation capital and national specialists. These 11 providers make their geographic reach and financing models explicit.
Use this list to build a focused research queue. Start with your company’s stage, the evidence you have and the milestone the round should finance. Then choose a small set of relevant providers, confirm the current mandate and plan an appropriate first conversation.
Brisbane capital at a glance
This is a selective, unranked directory of 11 provider families. A venture fund, angel network, co-investor and growth or strategic investor can serve different company needs. The scope column records geographic, institutional or investment-stage context, not a claim that every organization is headquartered locally.
| Provider | Capital route | Investment scope |
|---|---|---|
| TEN13 | Network-driven VC | Australian and wider technology founders |
| Sprint Ventures | Early and growth VC | Brisbane; globally focused teams |
| QIC Ventures | Institutional VC | Queensland-based; Australian innovation |
| Brisbane Angels | Angel group | Brisbane and wider Australian startup opportunities |
| Uniseed | Research-commercialisation VC | Australian research partner institutions |
| Main Sequence | Deep-tech VC | Australian deep-tech ecosystem |
| Flying Fox Ventures | Early-stage investor | Australia and New Zealand early-stage companies |
| Blackbird | VC | Australia-New Zealand startup ecosystem |
| AirTree | VC | Australian and New Zealand founders |
| Brandon Capital | Life-sciences VC | Life sciences; national and international teams |
| Artesian | Multi-strategy manager with venture funds | Asia-Pacific and specialist venture mandates |
Match Queensland access with a credible commercial milestone
- Separate an angel-stage company from an operating business seeking growth capital.
- For research spinouts, check the institution and authorized commercialization route.
- Treat national and trans-Tasman funds as wider mandates, not automatically Brisbane-based teams.
Illustrative example: a Queensland deep-tech company has a prototype and a defined pilot customer. The first queue combines a local venture team, a research-commercialisation investor where the institutional connection fits, and a national deep-tech specialist. A separate general software company uses different evidence and a different shortlist.
Avoid this shortcut: Multiple QIC-managed vehicles are not automatically independent investors. Choose the relevant fund and confirm its criteria rather than inflating the provider count.
11 providers to research
1. TEN13
Network-driven VC. Australian and wider technology founders.
TEN13 invests from pre-seed to Series A and beyond and connects companies with an operator and investor network. TEN13 official information.
Prepare before outreach: Show the founder insight and specific product or customer milestone. A network model is not a promise of access to every member.
2. Sprint Ventures
Early and growth VC. Brisbane; globally focused teams.
Sprint describes a Brisbane-based early- and growth-stage investment approach combining financial, social and human capital. Sprint Ventures official information.
Prepare before outreach: Match the team’s current strategy with the company’s maturity and operating goals, rather than choosing solely by office proximity.
3. QIC Ventures
Institutional VC. Queensland-based; Australian innovation.
QIC Ventures describes capacity from pre-seed through Series C-plus and a platform connected to Australian research, founders and global capital. QIC Ventures official information.
Prepare before outreach: Identify the applicable fund and mandate, and do not count every QIC-managed state vehicle as a separate independent investor.
4. Brisbane Angels
Angel group. Brisbane and wider Australian startup opportunities.
Brisbane Angels coordinates investor assessment of early-stage and seed opportunities through its member network. Brisbane Angels official information.
Prepare before outreach: Prepare the founder application and a clear financing milestone; individual members make investment decisions rather than guaranteeing a pooled cheque.
5. Uniseed
Research-commercialisation VC. Australian research partner institutions.
Uniseed is owned by research organizations and CSIRO and backs deep-tech and life-sciences companies from the laboratory onward. Uniseed official information.
Prepare before outreach: For a Queensland spinout, establish the institutional and research-rights connection before approaching the fund’s relevant team.
6. Main Sequence
Deep-tech VC. Australian deep-tech ecosystem.
Main Sequence organizes its investment work around major technical challenges, including industrial productivity, healthcare and decarbonisation. Main Sequence official information.
Prepare before outreach: For a Brisbane scientific or industrial startup, show the technical constraint, validation evidence and commercial deployment path.
7. Flying Fox Ventures
Early-stage investor. Australia and New Zealand early-stage companies.
Flying Fox provides early-stage capital to Australian and New Zealand companies with global ambitions. Flying Fox Ventures official information.
Prepare before outreach: Use it as a national option beyond Brisbane, with a focused customer wedge and plausible global market.
8. Blackbird
VC. Australia-New Zealand startup ecosystem.
Blackbird invests from the earliest company stages and publishes New Zealand founder and community activity. Blackbird official information.
Prepare before outreach: Separate company ambition from immediate proof and confirm the relevant team’s thesis rather than assuming every Queensland company is a fit.
9. AirTree
VC. Australian and New Zealand founders.
AirTree backs Australian and Kiwi technology founders and provides public company-building resources. AirTree official information.
Prepare before outreach: Research the sector and partner fit. Use public company-building resources for preparation without confusing them with investment approval.
10. Brandon Capital
Life-sciences VC. Life sciences; national and international teams.
Brandon backs life-sciences companies from proof of concept toward commercialisation, with scientific and investment teams. Brandon Capital official information.
Prepare before outreach: For a Queensland healthcare or scientific business, bring the development evidence and milestones relevant to a specialist life-sciences investor.
11. Artesian
Multi-strategy manager with venture funds. Asia-Pacific and specialist venture mandates.
Artesian manages both credit and venture strategies, with specialist venture funds for different industries and geographies. Artesian official information.
Prepare before outreach: Choose the actual venture fund and sector team. A wider credit or alternative-asset mandate is not equivalent to startup venture equity.
Turn the directory into your next five research actions
Choose five providers with a plausible mandate match, not five familiar logos. For each one, keep a source and one unresolved fit question beside the next action. Leave unknown information blank until you can verify it.
A compact investor-fit worksheet
Copy one record per provider. Replace the bracketed fields with company-specific evidence.
Brisbane investor research
Provider: [name and specific fund]
Official source + checked date: [URL, date]
Why our stage and technology fit: [evidence]
Geographic or institutional connection: [evidence]
Milestone this round finances: [specific result]
Open fit question: [one question]
Introduction or founder route: [verified route]
Owner + next action + date: [person, action, date]
Decision: [research next / ask a question / hold]Move a provider forward when the current mandate and your company evidence match. Ask a question when one material criterion is unclear. Hold when the fund is at the wrong stage, serves a different company geography or expects evidence you do not yet have. Do not treat a contact record as investor interest.
Give Aurora, Claude or Codex a focused research mission
Use this prompt with Aurora in Finta, Claude or Codex. Add only material you are authorized to share. Review the result before adding records or contacting anyone.
Be my Brisbane investor-research teammate.
Company: [one sentence, stage and location]
Technology or business model: [specific scope]
Evidence we have: [authorized facts only]
Next financing milestone: [result to fund]
Candidates: [paste five provider names from this guide]
Check each provider's current official sources.
Return: fit evidence, source URL/date, one open question, next action.
Separate local presence, investment reach and eligibility.
Mark missing facts unknown; do not invent cheque sizes or contacts.
Check portfolio conflicts before suggesting sensitive material.
Draft a research queue only. Do not contact or submit to anyone.Keep the next step moving
A useful shortlist connects investor fit to a relationship owner and a specific next action. Use Finta’s investor-prospecting workflow to organize the research. Keep the official source, contact context and follow-up together in your fundraising pipeline.
Before asking for an introduction, review portfolio conflicts and prepare a relevant message. The warm-introduction guide explains how to make a clear, permission-aware request. A possible path is not a completed introduction or a financing commitment.
A common founder question
Must a Brisbane startup use Queensland-only capital?
No. National investors can be appropriate when they match the company’s stage and market. The list labels that broader reach so local presence is not confused with investment scope.
How this list was researched
Research reviewed on October 28, 2026 using the linked official investment, portfolio and program pages. We count related firms and vehicles as one provider family where noted. Order is not a performance ranking. Public mandate evidence does not establish uncommitted capital, an open application window or an offer to invest; confirm the current process directly. The cover is an illustrative ecosystem, not a literal map or an investor-network diagram.
Authored by Finta Editorial Team. Source review was AI-assisted; hypothetical examples are labelled illustrative and are not customer results.
Informational guidance
This content is for general informational and educational purposes, not personalized investment, financial, legal or tax advice. Finta is not a law firm. Consult your attorney or accountant about financing documents, eligibility, intellectual property, tax treatment and your company’s circumstances.